|
|
Article: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics.(Industry overview)
- Article from:
- Business Wire
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
http://www.zacks.com/
CHICAGO -- Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Big Pharma & Biotech Industry, including Alcon (NYSE: ACL), Novartis (NYSE: NVS), Gilead Sciences (Nasdaq: GILD), Biogen Idec (Nasdaq: BIIB) and Acorda Therapeutics (Nasdaq: ACOR).
A synopsis of today's Industry Outlook is presented below. The full article can be read at http://www.zacks.com/stock/news/27081/Big+Pharma+and+Biotech.
In the pharma space, we are positive on stocks like Alcon (NYSE: ACL) and Novartis (NYSE: NVS). We believe these companies will continue witnessing revenue growth based on continued ...
Related newspaper, magazine, and journal articles:
|
|
Article: Zacks Analyst Blog Highlights: Facet Biotech Corporation, ...
Zacks Investment Research -;
October 12, 2009 ;
700+ words
... ... Biotech Corporation, Biogen Idec Inc., Trubion Pharmaceuticals ... Myers Squibb and Acorda Therapeutics For Immediate Release ... Corporation ( ), Biogen Idec Inc. ( ), Trubion ... Myers Squibb ( ) and Acorda Therapeutics ( ). Get the most ...
|
|